"Philips Halts US Sales of Sleep Apnea Machines Amid Ongoing Safety Concerns"

Philips will stop selling its sleep apnea machines in the US after a global recall due to potential health risks associated with the polyester-based polyurethane foam used in the devices. The company has agreed to a consent decree with the FDA and the Department of Justice, potentially costing it nearly $400 million. The recall affects approximately 5 million CPAP machines and ventilators, with concerns about inhaling or swallowing foam particles and chemicals. Philips will continue to service existing machines in the US but cannot sell new ones until required changes are made.